The U.S. plans to slash the price it pays for the Novo Nordisk A/S blockbusters Ozempic and Wegovy, the latest drugs to be targeted under legislation that’s expected save the government more ...

Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce costs for older adults and people with disabilities.

Drugs used to treat cancer, diabetes and other chronic conditions are among 15 picked for negotiations that could result in lower prices for patients, the Department of Health and Human Services ...

At the top of the list is Novo Nordisk's blockbuster diabetes injection Ozempic, weight loss shot ... it expects those negotiated prices to save Medicare enrollees around $1.5 billion in out ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will be subject to the next round of Medicare price negotiations, the Biden ...

About 7 million older adults on Medicare used the drugs and had to pay a portion of the bill at the pharmacy or via mail order. One in 5 older adults don't fill prescriptions or skip doses to save ...

Ozempic and Wegovy ... to the next round of Medicare price negotiations, the Biden administration announced Friday. But how much consumers will ultimately save depends on many factors, including ...

Popular diabetes drugs such as Ozempic and Trulicity ... or skip doses to save money, the report said. About 53 million Americans were enrolled in a Medicare prescription drug plan in 2024.

with a goal of lowering costs for Medicare patients. Advertisement Popular diabetes drugs Ozempic, Rybelsus and Wegovy, which are also used for weight loss are among the 15 announced Friday.